Related Image: Bumrungrad International the first private hospital to be awarded Thailand Quality Class (TQC) for organizational excellence |
(Date:11/26/2009)...25 years, the number of Americans living with diab...ion in 2009 to 44.1 million in 2034. Over the same...rising from $113 billion to $336 billion, even wit...chers based at the University of Chicago report in...mber of those with diabetes covered by Medicare wi...
(Date:11/26/2009)... Dr. David Kim of the Live Life Again C... Dallas , is one of a growing number of physicians...rking sites to connect with individuals who are in...t morbid obesity. Dr. Kim is utilizing Facebook to...ut his practice with the community. , ...
(Date:11/25/2009)...CITY,Mo.,Nov.25/PRNewswire/--TheBartleHallConventi...icalcliniconDec.9-10,whenKansasCityhoststhelatesti..., "Thisfreecliniceventhasthepotentialtobethebigg...ustoneandbeheldonweekdaysinsteadofoveraweekend,"Sh...ClinicandpresidentoftheNationalAssociationofFreeCl...
(Date:11/25/2009)...SPRING,Md.,Nov.25/PRNewswire-USNewswire/--Anarticl...rugEvaluationandResearch,titled"ADifficultBalance-...ov.26,2009issueofTheNewEnglandJournalofMedicine. ,...090824/FDALOGO ) ,, Inthearticle,Woodcockdiscus...dicationforthosewhoneeditandmanagingtherisksposedb...
(Date:11/25/2009)...have found evidence of a statistically significant...tients whose estrogen receptor (ER)-positive tumor...at serine-118 (ER-alpha S118-P), according to a br...the Journal of the National Cancer Institute . ,...tant to tamoxifen. Preclinical studies have shown ...
Breaking Medicine News(10 mins):Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Kansas City Prepares for Largest Free Health Clinic 2(Date:11/24/2009)...ov.24/PRNewswire/-- EisaiInc.andPfizerIncannounce...acceptedforreviewEisai,sNewDrugApplication(NDA)for...ease)tabletsforthetreatmentofmoderatetosevereAlzhe...ains23mgofdonepezilHClinanextendedrelease,matrix-t...leaseofthedrug.TheNDAisbasedonahead-to-headclinica...
(Date:11/24/2009)...swire-FirstCall/--ThoratecCorporation(Nasdaq: THOR...supporttherapiestosave,supportandrestorefailinghea...ualPiperJaffrayHealthCareConferenceonTuesday,Decem...chieffinancialofficer,willprovideanupdateonthecomp...m.,PacificStandardTime). ,, Thepresentationwill...
(Date:11/24/2009)...re/--ZargisMedicalCorp.,asubsidiaryofSpeedusCorp.(...arch(NYSE: SI ),todayannouncedthatitsZargisCardios...BS, TheEarlyShow duringasegmentinwhichMarkJannot,t...ningproductsfromthepublication,s2009"BestofWhat,sN...evisionmorningnewstalkshowbroadcastbyCBSfromNewYor...
Breaking Medicine Technology:FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Zargis Cardioscan(TM) Featured on The Early Show on CBS 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 3MedAssurant to Support AHIPs Research Capabilities 57024 1MedAssurant to Support AHIPs Research Capabilities 57024 2Thoratec Presentation at UBS Conference to be Webcast 57022 1Enobia Announces Positive Clinical Results With ENB 0040 a Bone Targeted Enzyme Replacement Therapy for Hypophosphatasia 4996 1Enobia Announces Positive Clinical Results With ENB 0040 a Bone Targeted Enzyme Replacement Therapy for Hypophosphatasia 4996 2Enobia Announces Positive Clinical Results With ENB 0040 a Bone Targeted Enzyme Replacement Therapy for Hypophosphatasia 4996 3...INGSTON, N.J.--(BUSINESS WIRE)--Jun 25, 2007 - Col...today that an interim,analysis of a pregnancy stud...erone gel) to compounded intramuscular progesteron...l be published in,Fertility and Sterility, the jou...cine (ASRM)., This ongoing prospective randomized ...
...YMOUTH MEETING, Pa., June 25, 2007 /PRNewswire-Fir...t data from a preclinical,study of trodusquemine (...ted during the American Diabetes Association (ADA)...IL. Dr. Kristen Lantz,Genaera research scientist ...rodusquemine is a Multiple Pathway Inhibitor that,...
Other Medicine Technology:Interim Analysis of Crinone Pregnancy Study to Be Published in,American Society for Reproductive Medicine Journal 2Interim Analysis of Crinone Pregnancy Study to Be Published in,American Society for Reproductive Medicine Journal 3Interim Analysis of Crinone Pregnancy Study to Be Published in,American Society for Reproductive Medicine Journal 4Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for,the Treatment of Obesity at the American Diabetes Association 67th,Scientific Session 2Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for,the Treatment of Obesity at the American Diabetes Association 67th,Scientific Session 3Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for,the Treatment of Obesity at the American Diabetes Association 67th,Scientific Session 4